Action Point Financial Planning’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-45
Closed -$2.46K – 879
2026
Q2
$2.46K Buy
+45
New +$2.37K ﹤0.01% 2159

Other funds holding CRSP

Action Point Financial Planning's CRSP Position: Q3 2026 in Review

Action Point Financial Planning sold out of CRISPR Therapeutics (CRSP) in Q3 2026, closing a stake of 45 shares — an estimated $2.46K sold.

Action Point Financial Planning first reported a position in CRSP in Q2 2026 and held it in 1 quarter. The position peaked at $2.46K in Q2 2026. 503 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.

  • Action Point Financial Planning reported no remaining CRISPR Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 45 CRISPR Therapeutics shares in Q3 2026, an estimated $2.46K.
  • Action Point Financial Planning first reported a position in CRISPR Therapeutics in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's CRISPR Therapeutics position peaked at $2.46K in Q2 2026.
  • 503 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.